Position in LXRX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$207,856
+$92,874 QoQ
Shares Held
86,607
+17.5% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#55
of 148 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF NOVA SCOTIA holds $233,247,691 across 19 Biotechnology names. LXRX ranks #18 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
181,706 | $113,300,959 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
1,238,830 | $43,842,193 | |
| 3 | EXEL |
Exelixis, Inc.
|
419,730 | $22,837,509 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
73,879 | $13,836,059 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
27,607 | $13,713,225 | |
| 6 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
133,805 | $10,906,445 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
68,548 | $5,435,170 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
8,130 | $2,447,373 |
All Filings in LXRX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $207,856 | 86,607 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $114,982 | 73,707 | Shares | Sole | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||